Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
Publication
, Journal Article
Vergouwen, MDI; Vermeulen, M; Roos, YBWEM
Published in: Neurology
April 21, 2009
Duke Scholars
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
April 21, 2009
Volume
72
Issue
16
Start / End Page
1447
Location
United States
Related Subject Headings
- Stroke
- Neurology & Neurosurgery
- Intracranial Arteriosclerosis
- Iatrogenic Disease
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Drug-Related Side Effects and Adverse Reactions
- Clinical Trials as Topic
- Cerebral Hemorrhage
Citation
APA
Chicago
ICMJE
MLA
NLM
Vergouwen, M. D. I., Vermeulen, M., & Roos, Y. B. W. E. M. (2009). Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology, 72(16), 1447. https://doi.org/10.1212/01.wnl.0000346744.56398.e5
Vergouwen, Mervyn D. I., M. Vermeulen, and Yvo B. W. E. M. Roos. “Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.” Neurology 72, no. 16 (April 21, 2009): 1447. https://doi.org/10.1212/01.wnl.0000346744.56398.e5.
Vergouwen MDI, Vermeulen M, Roos YBWEM. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2009 Apr 21;72(16):1447.
Vergouwen, Mervyn D. I., et al. “Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.” Neurology, vol. 72, no. 16, Apr. 2009, p. 1447. Pubmed, doi:10.1212/01.wnl.0000346744.56398.e5.
Vergouwen MDI, Vermeulen M, Roos YBWEM. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2009 Apr 21;72(16):1447.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
April 21, 2009
Volume
72
Issue
16
Start / End Page
1447
Location
United States
Related Subject Headings
- Stroke
- Neurology & Neurosurgery
- Intracranial Arteriosclerosis
- Iatrogenic Disease
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Drug-Related Side Effects and Adverse Reactions
- Clinical Trials as Topic
- Cerebral Hemorrhage